LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2020 Results - Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (LGND)
Q2 2020 Earnings Conference Call
August 03, 2020 08:30 AM ET
Company Participants
Patrick O'Brien - Investor Relations
John Higgins - Chief Executive Officer
Matt Korenberg - Executive Vice President, Finance & Chief Financial Officer
Matt Foehr - President & Chief Operating Officer
Conference Call Participants
Matt Hewitt - Craig-Hallum Capital Group
Joe Pantginis - H.C. Wainwright
Balaji Prasad - Barclays
Larry Solow - CJS Securities
Scott Henry - Roth Capital
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Ligand Pharmaceuticals Q2 2020 Earnings Conference